Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Breast Cancer

Articles and resources on breast cancer for patients, caregivers, and family members

A Breakthrough in the Treatment of Metastatic Triple-Negative Breast Cancer
Recently, Tecentriq became the first immunotherapy to be approved for the treatment of patients with metastatic triple-negative breast cancer, a particularly difficult type of breast cancer. Read More ›

The Good, the Bad, and the Funny: Making the Most of a Life Shaped by Breast Cancer
Enjoy Lillie Shockney’s sense of humor as you read her personal story of how working as a nurse and facing her own breast cancer diagnosis shaped her life and her lifelong work as a breast cancer educator and advocate. Read More ›

Listening to Our Instincts
Teresa Todt could not shake the nagging feeling that the pain in her breast was something serious, but repeated visits to her gynecologist and a mammogram didn’t lead anywhere. It was only after she found blood in her bra that additional tests showed she had invasive breast cancer. Read More ›

“You Will Live”
Samantha Anderson refused to give up when her triple-negative breast cancer returned. Trusting her oncologist, she enrolled in the clinical trial with Tecentriq (atezolizumab) that led to the approval of the first immunotherapy for this type of breast cancer. Read More ›

Keytruda plus Chemotherapy in Triple-Negative Breast Cancer
Triple-negative breast cancer is an aggressive type of cancer that usually has a high rate of disease recurrence (returning) within the first 5 years after diagnosis. Read More ›

Do I Have Bone Cancer, Lung Cancer, or Breast Cancer?
If you have been told you have metastatic breast cancer, make sure you understand what that means. Where did the cancer travel? Read More ›

Kadcyla Approved for Adjuvant Treatment of HER2-Positive Early Breast Cancer with Residual Invasive Disease

Piqray New Treatment Approved for Metastatic Breast Cancer and PI3KCA Mutation
In May 2019, the FDA approved Piqray (alpelisib), the first PI3K inhibitor for the treatment of metastatic breast cancer with a PI3KCA mutation in postmenopausal women, and in men. An FDA spokesperson said it was the first treatment “to demonstrate a clinically meaningful benefit” for this type of breast cancer. Read More ›

FDA Calls Attention to Risk Associated with Breast Implants: Anaplastic Large-Cell Lymphoma
In February 2019, the FDA issued a letter to raise awareness of the risk for a rare type of lymphoma, BIA-ALCL, that is linked to all types of breast implants. Although this is an uncommon reaction to implants, all women who have or intend to get an implant after breast cancer should be aware of this risk. Learn more about this risk here. Read More ›

Supporting Teenage Children Whose Mothers Have Metastatic Breast Cancer
Two-time breast cancer survivor and breast cancer expert Lillie Shockney offers insightful advice to mothers with metastatic disease on how not to burden their teens with heavy expectations, and instead allow them to have “teenager time.” Read More ›

Page 12 of 19